Download presentation
Presentation is loading. Please wait.
1
HS 4160 Critical Scientific Analysis
Week 8: Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation Depends on Cytogenetic Risk for Acute Myeloid Leukemia in First Disease Remission HS 4160 Critical Scientific Analysis
2
True. False. From my search outside of this paper, I understand that allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a procedure in which a person receives blood-forming stem cells from a genetically similar, but not identical, donor such as sister or brother.
3
True. False. From my search outside of this paper, I understand that autologus hematopoietic stem cell transplantation (auto-HSCT) is a procedure in which a person receives his/her own blood-forming stem cells after high-dose chemotherapy with or without radiotherapy with the intention of eradicating his/her malignant cell population.
4
What is the objective(s) of the study?
To identify the karyotype of AML patients who received allo-HSCT and were in first complete remission. To identify the efficacy of allo-HSCT for patients with AML in second complete remission. To identify the efficacy of allo-HSCT for patients with AML in first complete remission. To identify the karyotype of AML patients who received allo-HSCT and were in second complete remission.
5
Which of the following regarding to AML and allo-HSCT is NOT true?
Efficacy comparison between allo-HSCT and auto-HSCT is usually biased due to many uncontrolled factors. Allo-HSCT is less effective than auto-HSCT. More than 70% young AML patients could achieve complete remission. Karyotyping is the most relevant prognostic marker for AML.
6
All of the following were inclusion criteria EXCEPT:
Original paper in English. Studies dealing only with children. Used overall survival as outcome. Published between 1995 and 2003.
7
Based on the result from table 1, _____ overall survival hazard ratio subgroup comparison were significant. 4 3 2 1
8
Which statistic software was used for this study?
SAS. SPSS. STATA. CMA.
9
Favorable. Intermediate. Poor. Unknown.
inv(16)/t(16;16)/del(16q) was considered as ________ by all three groups according to table 2? Favorable. Intermediate. Poor. Unknown.
10
study ID 2-1. study ID 3-4. study ID 4-4. study ID 5-4.
Which of the following study carried more weight when compared to the rest based on Figure 1? study ID 2-1. study ID 3-4. study ID 4-4. study ID 5-4.
11
This chromosome abnormality is associated with poor outcome according to table 2.
del(5q). t(15;17). inv(16).
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.